| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1286 | |
| Phytochemical name or plant extracts | n-butyl-alpha-D-fructofuranoside | |
| PMID | 21761727 | |
| Literature evidence | The isolated compounds(1-9) showed positive anti-tumor metastatic activities, and compounds 1, 5, and 8 showed significant anti-tumor metastatic activities. | |
| IUPAC name | (2R,3S,4S,5R)-2-butoxy-2,5-bis(hydroxymethyl)oxolane-3,4-diol | |
| Phytochemicals’ class or type of plant extracts | Glycoside | |
| Source of phytochemicals or plant Extracts | Ardisia Crenata | |
| Geographical availability | Assam, Cambodia, China South-Central, China Southeast, Hainan, India, Japan, Korea, Laos, Malaya, Myanmar, Nansei-shoto, Philippines, Sri Lanka, Taiwan, Thailand, Tibet, Vietnam | |
| Plant parts | NA | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | At the concentration of 0.8 mg x L(-1), compound 5 revealed the value of metastatic inhibition ratio on MDA-MB-231 was 93.8%. | |
| Cell line/ mice model | MDA-MB-231 | |
| Additional information | NA | |
| PubChem ID | 13386213 | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:586890-1 | |
| Safety | NA |